Harbor Health Care ETF (MEDI) is an ETF managed by Independent / Boutique. Its largest position is ELI LILLY & Co (LLY), representing 20.10% of fund assets.
Harbor Health Care ETF Portfolio Holdings
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- MEDI
- Type:
- ETF
- Manager:
- Independent / Boutique
- Total Assets:
- —
- Report Date:
- Apr 30, 2026
- Filing Date:
- Jun 26, 2026
| Holding | Weight | Market Value | Shares |
|---|---|---|---|
|
-
ELI LILLY & Co
|
20.10% | $5,541,243.40 | 5,929 |
|
-
Ascendis Pharma A/S
|
15.56% | $4,289,176.62 | 18,699 |
|
-
Legend Biotech Corp
|
5.13% | $1,415,645.28 | 60,189 |
|
-
AbbVie Inc.
|
4.78% | $1,317,580.20 | 6,235 |
|
-
Vaxcyte, Inc.
|
4.64% | $1,279,714.68 | 22,357 |
|
-
INTUITIVE SURGICAL INC
|
4.53% | $1,247,902.47 | 2,727 |
|
-
RHYTHM PHARMACEUTICALS, INC.
|
3.79% | $1,043,930.16 | 12,831 |
|
-
INSMED Inc
|
3.71% | $1,023,701.97 | 7,509 |
|
-
Abivax S.A.
|
3.54% | $974,723.52 | 8,304 |
|
-
DANAHER CORP /DE/
|
2.43% | $669,094.05 | 3,739 |
|
-
Revolution Medicines, Inc.
|
2.38% | $655,169.52 | 4,546 |
|
-
Natera, Inc.
|
2.35% | $647,754.72 | 3,142 |
|
-
Cencora, Inc.
|
2.16% | $595,999.35 | 1,935 |
|
-
GeneDx Holdings Corp.
|
2.12% | $584,248.10 | 9,290 |
|
-
Merck & Co., Inc.
|
2.00% | $551,140.64 | 5,048 |
|
-
IDEXX LABORATORIES INC /DE
|
1.84% | $506,402.40 | 903 |
|
-
UNITEDHEALTH GROUP INC
|
1.77% | $487,181.20 | 1,315 |
|
-
NOVO NORDISK A S
|
1.19% | $327,880.52 | 7,766 |
|
-
VERTEX PHARMACEUTICALS INC / MA
|
1.16% | $320,535.00 | 750 |
|
-
BOSTON SCIENTIFIC CORP
|
1.10% | $302,567.72 | 5,252 |
|
-
NEWAMSTERDAM PHARMA CO NV
|
1.09% | $300,936.72 | 10,537 |
|
-
ALNYLAM PHARMACEUTICALS, INC.
|
1.08% | $298,967.34 | 966 |
|
-
Adaptive Biotechnologies Corp
|
1.06% | $291,517.50 | 20,675 |
|
-
Guardant Health, Inc.
|
1.02% | $280,223.44 | 3,218 |
|
-
MADRIGAL PHARMACEUTICALS, INC.
|
0.90% | $246,795.03 | 477 |
|
-
DEXCOM INC
|
0.84% | $231,530.40 | 3,888 |
|
-
RadNet, Inc.
|
0.77% | $211,044.60 | 3,732 |
|
-
IONIS PHARMACEUTICALS INC
|
0.58% | $160,958.28 | 2,153 |
|
-
NUVALENT INC-A
|
0.58% | $160,347.72 | 1,599 |
|
-
Scholar Rock Holding Corp
|
0.57% | $157,728.24 | 3,384 |
|
-
INSULET CORP
|
0.57% | $157,163.82 | 913 |
|
-
Immunovant, Inc.
|
0.55% | $151,713.41 | 5,589 |
|
-
Praxis Precision Medicines, Inc.
|
0.50% | $138,053.39 | 433 |
|
-
Avalo Therapeutics, Inc.
|
0.50% | $136,921.20 | 10,218 |
|
-
Xenon Pharmaceuticals Inc.
|
0.50% | $136,625.52 | 2,438 |
|
-
Relay Therapeutics, Inc.
|
0.48% | $132,049.44 | 10,189 |
|
-
BIO-TECHNE Corp
|
0.48% | $131,329.68 | 2,374 |
|
-
Oruka Therapeutics, Inc.
|
0.46% | $126,284.86 | 1,846 |
|
-
iRhythm Holdings, Inc.
|
0.45% | $122,702.00 | 950 |
|
-
SOPHiA GENETICS SA
|
0.33% | $91,887.66 | 17,603 |
Advertisement (320x50)